Pharmaceuticals

AbbVie and Gilgamesh Pharmaceuticals agree to terms of collaboration to develop advanced treatments for mental illnesses

bexib
By bexib 0 Min Read

This joint venture aims to address unmet needs in the treatment of mood and anxiety disorders through novel neuroplastogens.

You Might Also Like

KCL Leads First-of-its-Kind Guidelines for Immune Monitoring of Hard-to-Treate Blood Cancers

Femasys founder talks about Femaseed’s technology designed to support fertility treatment

AARP Pennsylvania survey finds health care costs and related issues could influence people’s voting habits

FDA grants priority review to Novartis’ Sembrix for newly diagnosed patients with chronic-phase Philadelphia chromosome-positive chronic myeloid leukemia

What’s the secret to transforming an academic idea into a valuable product that potential customers crave?

Share This Article
Previous Article Fiat Debases Marriage
Next Article Zone management with Wes Anderson and Johanna Lindeboom – RealAgriculture
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Stay Connected

Latest News

Progress of metal cutting technology: Innovative innovation, sustainability, and future labor
Manufacturing
Ceratizit showcases innovation, sustainability and cutting-edge solutions at IMTEX 2025
Manufacturing
Goldman launches an internal GEN AI Assistant with 10K employees
Banking
Taiwan emerges as key player in Indian machine tools market with 20.8% growth
Manufacturing